U. YILMAZ Et Al. , "An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date," DRUG DESIGN DEVELOPMENT AND THERAPY , vol.15, pp.3809-3820, 2021
YILMAZ, U. Et Al. 2021. An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.15 , 3809-3820.
YILMAZ, U., SALİHOĞLU, A., & Soysal, T., (2021). An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date. DRUG DESIGN DEVELOPMENT AND THERAPY , vol.15, 3809-3820.
YILMAZ, Umut, Ayşe SALİHOĞLU, And Teoman SOYSAL. "An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date," DRUG DESIGN DEVELOPMENT AND THERAPY , vol.15, 3809-3820, 2021
YILMAZ, Umut Et Al. "An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.15, pp.3809-3820, 2021
YILMAZ, U. SALİHOĞLU, A. And Soysal, T. (2021) . "An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date." DRUG DESIGN DEVELOPMENT AND THERAPY , vol.15, pp.3809-3820.
@article{article, author={Umut YILMAZ Et Al. }, title={An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date}, journal={DRUG DESIGN DEVELOPMENT AND THERAPY}, year=2021, pages={3809-3820} }